tiprankstipranks
Trending News
More News >
Prime Medicine, Inc. (PRME)
NASDAQ:PRME
US Market

Prime Medicine, Inc. (PRME) Similar Stocks

Compare
837 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Prime Medicine, Inc.
$3.69
$666.08M
-2.50
33.70%
4 Buy
3 Hold
0 Sell
Moderate Buy
Immatics
$9.57
$1.37B
-9.34
43.94%
6 Buy
0 Hold
0 Sell
Strong Buy
Relay Therapeutics
$8.31
$1.44B
-4.75
96.45%
5 Buy
1 Hold
0 Sell
Strong Buy
Taysha Gene Therapies
$5.71
$1.56B
-16.11
208.65%
12 Buy
0 Hold
0 Sell
Strong Buy
Sana Biotechnology
$4.53
$1.21B
-4.67
158.86%
4 Buy
0 Hold
0 Sell
Strong Buy
Upstream Bio, Inc.
$26.97
$1.58B
-12.79
50.57%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PRME
Prime Medicine, Inc.
3.69
0.75
25.51%
IMTX
Immatics
10.22
3.16
44.76%
RLAY
Relay Therapeutics
8.31
3.86
86.74%
TSHA
Taysha Gene Therapies
5.71
3.85
206.99%
SANA
Sana Biotechnology
4.53
2.83
166.47%
UPB
Upstream Bio, Inc.
29.21
9.77
50.26%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts